Advertisement

Japanese Journal of Rheumatology

, Volume 9, Issue 3, pp 267–272 | Cite as

Thrombotic thrombocytopenic purpura in a patient with a diffuse form of systemic sclerosis

  • Kiyomi Sadamoto
  • Eizo Saito
  • Takehiko Ogawa
  • Hidenari Fukuya
  • Masao Kinoshita
Case Report

Abstract

This paper presents a patient with a rapidly progressive diffuse form of systemic sclerosis, in whom a clinical course thrombotic thrombocytopenic purpura (TTP) also developed. In spite of treatment with plasmapheresis, predonisolone, aspirin and vincristine, she died of pulmonary bleeding. From the analysis of four other reported cases of scleroderma with TTP and this case, the outcome of TTP seems to be closely related to clinical manifestations. It is suggested that a diffuse form of scleroderma with interstitional manifestations would develop a worse outcome; on the other hand, a limited form without interstitional manifestations has a successful outcome.

Key words

Thrombotic thrombocytopenic purpura systemic sclerosis plasma exchange vincristine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Becker RC, Giuliani M, Weick JK, Thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus,Cleve Clin Q 52, 409–415 (1985).PubMedGoogle Scholar
  2. 2.
    Blackman NS, Cohen BM, Watson J, Thrombotic thrombocytopenic purpura; report of a case,J Am Med Ass 148, 546–548 (1952).Google Scholar
  3. 3.
    Benitez L, Mathews M, Mallory GK, Platelet thrombosis with polyarthritis nodosa; report of a case,Arch Pathol 77, 116–125 (1964).PubMedGoogle Scholar
  4. 4.
    Steinberg AD, Green WR, Talal N, Thrombotic thrombocytopenic purpura complicating Sjogren’s syndrome,J Am Med Ass 215, 757–761 (1971).CrossRefGoogle Scholar
  5. 5.
    Borg EJ, Houtman PM, Kallenberg CGMet al., Thrombocytopenia and hemolytic anemia in a patient with mixed connective tissue disease due to thrombotic thrombocytopenic purpura,J Rheumatol 15, 1174–1177 (1988).PubMedGoogle Scholar
  6. 6.
    Saitoh M, Wada H, Tanigawa M, The change of von Willebrand factor multimer in a course of thrombotic thrombocytopenic purpura,Jpn J Clin Hematol 32, 1006–1008 (1991).Google Scholar
  7. 7.
    Cookson S, Micael LK, Pobert MB, Fulminat thrombotic thrombocytopenic purpura in a patient with the limited form of scleroderma; successful outcome using plasma exchange,J Rheumatol 18, 900–901 (1991).PubMedGoogle Scholar
  8. 8.
    Ricken DM, Sharma HM, Nahman NS Jr, A cute renal failure with glomerula thrombosis in a patient with chronic scleroderma,Am J Kidney Dis 14, 524–526 (1989).Google Scholar
  9. 9.
    Barton JC, Saway DA, Blackburn WDet al., Thrombotic thrombocytopenic purpura in systemic sclerosis,J Rheumatol 16, 1400–1401 (1989).PubMedGoogle Scholar
  10. 10.
    Ando J, Hanawa N, Inokuma Set al., Thrombotic thrombocytopenic purpura with pleural effusion complicating PSS,Kanto Regional conference 23, 191–201 (1990).Google Scholar
  11. 11.
    Kimberly RP, Pulse methylprednisolone in SLE,Clin Reum Dis 8, 261–278 (1982).Google Scholar
  12. 12.
    Cohen S, Johnsen AR, Hurd E, Cytotoxicity of patients with scleroderma: Effect on human endothelial cells and fibroblasts in culture,Arthritis Rheum 26, 170–178 (1983).PubMedCrossRefGoogle Scholar
  13. 13.
    Blitzer JB, Granfortuna JM, Gottlieb AJet al., Thrombotic thrombo-cytopenic purpura; treatment with plasma pheresis,Am J Hematol 24, 329–339 (1987).PubMedCrossRefGoogle Scholar
  14. 14.
    Lian ECY, Pathogenesis of thrombotic thrombocytopenic purpura,Semin Hematol 24, 82–100 (1987).PubMedGoogle Scholar

Copyright information

© VSP and Japanese Rheumatism Association 1999

Authors and Affiliations

  • Kiyomi Sadamoto
    • 1
  • Eizo Saito
    • 1
  • Takehiko Ogawa
    • 1
  • Hidenari Fukuya
    • 1
  • Masao Kinoshita
    • 1
  1. 1.Fourth Department of Medicine, School of MedicineToho University 2-17-6Meguro-ku, TokyoJapan

Personalised recommendations